韻達股份(002120.SZ):控股股東增持公司股份取得專項貸款承諾函
格隆匯5月16日丨韻達股份(002120.SZ)公佈,根據中國人民銀行聯合金融監管總局、中國證監會發布《關於設立股票回購增持再貸款有關事宜的通知》的相關規定,上海羅頡思符合主要股東增持股票的基本條件。近日,公司收到上海羅頡思通知,上海羅頡思已取得中國銀行股份有限公司上海長三角一體化示範區分行出具的《貸款承諾函》,中國銀行上海長三角分行承諾爲上海羅頡思增持公司股份提供貸款支持,貸款金額不超過18,000萬元人民幣(含);貸款期限不超過3年;貸款比例不超過90%。除上述貸款外,本次增持股份的資金來源爲上海羅頡思自有資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.